Stock Quote (NASDAQ: NSTG)
Price:
17.42
Change:
- 0.27
Day High:
17.77
Day Low:
17.31
Volume:
118,823
4:00 PM ET on Apr 21, 2017
Delayed at least 20 minutes.
Provided by eSignal.


Search Investor Relations

Committee Composition

  Audit Compensation Nominating and Corporate Governance
William D. Young Independent Director Member of Audit Committee   Member of Nominating and Corporate Governance Committee
Chairman of the Board

William D. Young has served as the chairman of the board of directors since January 2010 and as a member of the audit committee since November 2011 and nominating and corporate governance committee since September 2013. Mr. Young is a Venture Partner at Clarus Ventures, a health care and life sciences venture capital firm, which he joined in March 2010. Prior to joining Clarus Ventures, Mr. Young served from 1999 until June 2009 as Chairman of the board of directors and Chief Executive Officer of Monogram Biosciences, a biotechnology company acquired by Laboratory Corporation of America in June 2009. From 1980 to 1999 Mr. Young was employed at Genentech, a biotechnology company acquired by Roche in March 2009, most recently as Chief Operating Officer from 1997 to 1999, where he was responsible for all Product Development, Manufacturing and Commercial functions. Mr. Young joined Genentech in 1980 as Director of Manufacturing and Process Sciences and became Vice President in 1983. Prior to joining Genentech, Mr. Young worked at Eli Lilly & Co. for 14 years and held various positions in production and process engineering, antibiotic process development and production management. Mr. Young is retired Chairman of the board of directors of Biogen and a member of the boards of directors of Theravance Biopharma and Vertex Pharmaceuticals. Mr. Young received his M.B.A. from Indiana University and his B.S. in chemical engineering from Purdue University, and an honorary doctorate of engineering from Purdue University. Mr. Young was elected to The National Academy of Engineering in 1993 for his contributions to biotechnology.


Nicholas Galakatos, Ph.D. Independent Director   Committee Chair for Compensation  Committee Member of Nominating and Corporate Governance Committee
Robert M. Hershberg, M.D., Ph.D. Independent Director     Member of Nominating and Corporate Governance Committee
Gregory Norden Independent Director Committee Chair for Audit Committee Member of Compensation  Committee  
Chad Waite Independent Director Member of Audit Committee Member of Compensation  Committee Committee Chair for Nominating and Corporate Governance Committee
Committee Chair = Chair Committee Member = Member Independent Director = Independent Director